Dragon Pharma YK 11 10 mg - Oral Myostatin SARM Tablets

Dragon Pharma YK 11 10 mg - Research SARM Tablets

Dragon Pharma YK 11 10 mg supplies YK-11 as 100 tablets of 10 mg. It is described as a steroidal selective androgen receptor modulator, and it circulates with a myostatin-inhibitor label that comes from the title of a single research paper rather than from a sports protocol. No approved medicine in this category exists. YK 11 for sale from a GMP manufacturer with batch testing and a Certificate of Analysis on file.

• YK-11 10 mg per tablet, 100 tablets per pack
• Steroidal selective androgen receptor modulator, oral
• No confirmed human dose and no established half-life
• GMP-manufactured, HPLC-verified, COA on file per batch

How YK 11 Works

YK-11 binds the androgen receptor and is classed as steroidal because of its structure, which places it closer to a designer androgen than to the non-steroidal modulators such as Ligandrol or Ostarine. The overlapping myostatin story is often repeated in vendor material, but the fact sheet records that the myostatin logic appears only in the name of a 2021 paper on bacterial sepsis, not as an athletic protocol. There is no pharmacokinetic profile, so the timing of effects cannot be modelled. Reported effects include liver damage, suppression of natural testosterone, lipid shifts, and reports of increased aggression and sleep problems.

Research Amounts and Handling

No human dose is confirmed for YK-11 at any level, and the fact sheet is explicit that extrapolating from cell studies is not a medical recommendation. The 10 mg tablet is simply the fixed pack unit this page carries, not a validated amount. Community material describes runs built around a testosterone base with recovery afterwards, and it also records that YK-11 should not be combined with other hepatotoxic orals. Monitoring follows the class pattern: ALT and AST, lipids, and testosterone with LH and FSH. Recovery is planned with Nolvadex or Clomid.

Quality & Authenticity

Every batch is produced under GMP conditions and checked by independent HPLC, with the Certificate of Analysis held for the batch, which is the only identity check available for an unapproved compound. Two other high-potency entries on the line are Testolone and S 23, and neither has a comfortable safety record either. Given the absence of any pharmacokinetic data, YK-11 is among the entries that should be treated as what it is: an uncharacterised laboratory material.

For laboratory research only. Consult a healthcare professional before use.

Consult a healthcare professional before any cycle. Doses are common community protocols.